Joel Sendek is CFO at Spero Therapeutics, Inc. (SPRO). They have made 1 open-market trade across 1 company since 2017, most recently 2018-07-05.
CIK 0001720875
1 open-market purchase totalling $70K since 2017, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SPRO | 15,181 | $17K |
Shares reported on the most recent Form 4, priced at the 2018-07-06 close.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.